GENERATION TIMES OF PROTEUS-MIRABILIS AND ESCHERICHIA-COLI IN EXPERIMENTAL INFECTIONS

被引:23
作者
EUDY, WW [1 ]
BURROUS, SE [1 ]
机构
[1] NORWICH PHARMACAL CO,EATON LABS,POB 191,NORWICH,NY 13815
关键词
D O I
10.1159/000221451
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:161 / 170
页数:10
相关论文
共 35 条
[2]  
ASSCHER AW, 1966, LANCET, V2, P1037
[3]  
ASSCHER AW, 1968, UROL DIGEST, V7, P22
[4]  
BARKER HA, 1961, BACTERIA, V2
[5]  
BEAR HE, 1970, VET MED SMALL ANIM C, V65, P43
[7]   RAT PYELONEPHRITIS MODEL SUITABLE FOR PRIMARY OR SECONDARY SCREENING [J].
BURROUS, SE ;
CAWEIN, JB .
APPLIED MICROBIOLOGY, 1969, 18 (03) :448-&
[8]   ENHANCEMENT OF AMPICILLIN EFFICACY BY PERORAL LEVODOPA IN RAT PYELONEPHRITIS [J].
BURROUS, SE ;
SIEDLER, AJ ;
EUDY, WW .
LIFE SCIENCES PT-2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1972, 11 (22) :1087-+
[9]   PYELONEPHRITIS THERAPY IN RATS - RANDOM ASSOCIATION WITH EXCRETED URINARY ANTIBACTERIAL ACTIVITY [J].
BURROUS, SE ;
FREEDMAN, R ;
CHAMBERLAIN, RE ;
BASSON, RP .
APPLIED MICROBIOLOGY, 1970, 20 (04) :598-+
[10]  
COON MJ, 1955, AMINO ACID METABOLIS